Cargando…

High-Risk Prostate Cancer: A Very Challenging Disease in the Field of Uro-Oncology

Detalles Bibliográficos
Autores principales:	Napodano, Giorgio, Ferro, Matteo, Sanseverino, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996958/ https://www.ncbi.nlm.nih.gov/pubmed/33652852 http://dx.doi.org/10.3390/diagnostics11030400

Ejemplares similares

Immune Checkpoint Inhibitors in Uro-Oncology: Urgent Call for Biomarkers
por: Pichler, Renate
Publicado: (2020)

COVID-19 research: promising tracks leading to uro-oncology
por: Tamás, Fazekas, et al.
Publicado: (2020)

Robotics in uro-oncologic surgery
por: De Lorenzis, Elisa, et al.
Publicado: (2013)

Positron emission tomography in uro-oncology
por: Hain, S F
Publicado: (2005)

Impact of COVID-19 pandemic on prostate cancer outcomes at an uro-oncology referral center
por: Andrade, Guilherme Miranda, et al.
Publicado: (2023)

COVID-19 pandemic impact on uro-oncological disease outcomes at an Italian tertiary referral center
por: Oderda, Marco, et al.
Publicado: (2021)

Uro-oncologic patient management during the COVID-19 pandemic: survey findings from an Italian oncologic hub
por: Luzzago, Stefano, et al.
Publicado: (2021)

Telehealth in Uro-oncology Beyond the Pandemic: Toll or Lifesaver?
por: Rodler, Severin, et al.
Publicado: (2020)

A Guide for Oncologic Patient Management during Covid-19 Pandemic: The Initial Experience of an Italian Oncologic Hub with Exemplificative Focus on Uro-Oncologic Patients
por: Mistretta, Francesco A., et al.
Publicado: (2020)

Value of multiphoton microscopy in uro-oncology: a narrative review
por: Treacy, Patrick-Julien, et al.
Publicado: (2023)

The importance of histopathologic review of biopsies in patients with prostate cancer referred to a tertiary uro - oncology center
por: Matheus, Wagner Eduardo, et al.
Publicado: (2019)

The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology
por: Risbridger, Gail P., et al.
Publicado: (2021)

Nefro-Uro /
Publicado: (2018)

Correction to: COVID-19 research: promising tracks leading to uro-oncology
por: Fazekas, Tamás, et al.
Publicado: (2020)

Application of Mass Spectrometry Imaging in Uro-Oncology: Discovering Potential Biomarkers
por: Czétány, Péter, et al.
Publicado: (2022)

Concerns in Redirecting Uro-oncologic Patients During COVID-19 Pandemic
por: Campodonico, Fabio, et al.
Publicado: (2020)

The Uro-oncology Patient and Vaccination Against SARS-CoV-2
por: Rodriguez Socarrás, Moises, et al.
Publicado: (2021)

Editorial: Technology advancements, social media and innovations in uro-oncology and endourology
por: Hameed, B M Zeeshan, et al.
Publicado: (2022)

Item analysis of G8 screening in uro-oncologic geriatric patients
por: Bouzan, J., et al.
Publicado: (2023)

Very-high-risk (VHR) localized prostate cancer: an indication for multimodal therapy
por: Sundi, Debasish, et al.
Publicado: (2019)

The Shift Towards Digital Appointments: the Response to COVID-19 Affecting Uro-Oncology
por: Scott, E., et al.
Publicado: (2021)

Impact of COVID-19 on Uro-Oncological Patients: A Comprehensive Review of the Literature
por: Gavi, Filippo, et al.
Publicado: (2023)

Essentials of Uro-Radiology
por: Kabala, J. E.
Publicado: (1991)

Haema-Uro-Chrome
Publicado: (1914)

Lessons from the coronavirus disease 2019 pandemic: Will virtual patient management reshape uro-oncology in Germany?
por: Rodler, Severin, et al.
Publicado: (2020)

The Experiences of Specialist Nurses Working Within the Uro-oncology Multidisciplinary Team in the United Kingdom
por: Punshon, Geoffrey, et al.
Publicado: (2017)

Strategies to successfully prevent COVID-19 outbreak in vulnerable uro-oncology patient population
por: Tamalunas, Alexander, et al.
Publicado: (2022)

How uro-oncology has been affected by COVID-19 emergency? Data from Piedmont/Valle d’Aosta Oncological Network, Italy
por: Oderda, Marco, et al.
Publicado: (2021)

Consensus statements on the management of clinically localized prostate cancer from the Hong Kong Urological Association and the Hong Kong Society of Uro‐Oncology
por: Ma, Wai‐Kit, et al.
Publicado: (2019)

Association between obesity and frequency of high-grade prostate cancer on biopsy in men: A single-center retrospective study
por: Baio, Raffaele, et al.
Publicado: (2022)

Evaluation of comorbidity indices in determining the most suitable candidates for uro-oncological surgeries in elderly men
por: Selvi, Ismail, et al.
Publicado: (2021)

Impact of COVID-19 Pandemic on Health-Related Quality of Life in Uro-oncologic Patients: What Should We Wait For?
por: Greco, Francesco, et al.
Publicado: (2021)

Impact of Previous Nephrectomy on Clinical Outcome of Metastatic Renal Carcinoma Treated With Immune-Oncology: A Real-World Study on Behalf of Meet-URO Group (MeetUro-7b)
por: Stellato, Marco, et al.
Publicado: (2021)

External Validation of the ASSURE Model for Predicting Oncological Outcomes After Resection of High-risk Renal Cell Carcinoma (RESCUE Study: UroCCR 88)
por: Khene, Zine-Eddine, et al.
Publicado: (2021)

Trends of risk classification and primary therapy for Japanese patients with prostate cancer in Nara Uro-Oncological Research Group (NUORG)–a comparison between 2004-2006 and 2007-2009
por: Tanaka, Nobumichi, et al.
Publicado: (2013)

The primary therapy chosen for patients with localized prostate cancer between the university hospital and its affiliated hospitals in Nara Uro-oncological research group registration
por: Tanaka, Nobumichi, et al.
Publicado: (2011)

Degarelix therapy for prostate cancer in a real-world setting: experience from the German IQUO (Association for Uro-Oncological Quality Assurance) Firmagon® registry
por: Geiges, Götz, et al.
Publicado: (2015)

The UroLift implant: mechanism behind rapid and durable relief from prostatic obstruction
por: Roehrborn, Claus G., et al.
Publicado: (2021)

Oncological and functional outcomes of high-risk and very high-risk prostate cancer patients after robot-assisted radical prostatectomy
por: Chen, Wei-Hsin, et al.
Publicado: (2023)

Rheumatic and oncological diseases – common challenges
por: Jeziorski, Krzysztof
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bnk26ie6l1ukukj08p4o3tphd0